This medication is an autologous (using the patient's own cells) cellular product, prescribed for the repair of symptomatic cartilage defects of the femoral condyle.
Contraindicated in patients with known hypersensitivity to gentamicin.
Cell doses per cmē of defect- 0.64 million to 3.3 million cells/cm
It comes as a vial, which contains approximately 12 million cells, should be inserted into the affected area.
Caution should be exercised in people who are at risk of infections, children, pregnant and breastfeeding women.
Interventions during subsequent surgical procedures:
Surgical removal of cartilage lesion, scars, surgical removal of joint tissue, surgery of the cartilage, removal of a torn meniscus (common knee joint injury), microfracture, scar tissue removal, hardware removal, joint surgeries.
Most Serious : Injury complications, graft overgrowth, knee pain, cartilage injury, graft complication, meniscal lesion, graft failure, joint inflammation.
Unstable meniscus tears or absent meniscus should be repaired or reconstructed before starting the Autologous Cultured Chondrocytes therapy.
Abnormal weight-distribution or instability of the knee should be corrected before initiating the treatment to achieve success rate.
Administration should be carried out only by the trained medical personnel.
Store it at room temperature. Do not freeze.
Subscribe to our Free Newsletters!